Anna Lembke

3.6k total citations · 1 hit paper
69 papers, 2.6k citations indexed

About

Anna Lembke is a scholar working on Public Health, Environmental and Occupational Health, Epidemiology and Psychiatry and Mental health. According to data from OpenAlex, Anna Lembke has authored 69 papers receiving a total of 2.6k indexed citations (citations by other indexed papers that have themselves been cited), including 30 papers in Public Health, Environmental and Occupational Health, 22 papers in Epidemiology and 15 papers in Psychiatry and Mental health. Recurrent topics in Anna Lembke's work include Opioid Use Disorder Treatment (25 papers), Substance Abuse Treatment and Outcomes (21 papers) and Pain Management and Opioid Use (8 papers). Anna Lembke is often cited by papers focused on Opioid Use Disorder Treatment (25 papers), Substance Abuse Treatment and Outcomes (21 papers) and Pain Management and Opioid Use (8 papers). Anna Lembke collaborates with scholars based in United States, Switzerland and Canada. Anna Lembke's co-authors include Terence A. Ketter, Alan F. Schatzberg, Jennifer Keller, Keith Humphreys, Laura C. Lazzeroni, Greer M. Murphy, G Williams, R Gomez, Jonathan H. Chen and Nancy A. Haug and has published in prestigious journals such as New England Journal of Medicine, Annals of Internal Medicine and American Journal of Psychiatry.

In The Last Decade

Anna Lembke

66 papers receiving 2.5k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

HPA axis in major depression: cortisol, clinical symptomatology and genetic variation predict cognition

2016 606 citations Jennifer Keller, R Gomez et al. Molecular Psychiatry profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Anna Lembke United States	26	713	476	435	368	357	69	2.6k
Karen Miotto United States	33	944 1.3×	333 0.7×	1.2k 2.8×	159 0.4×	87 0.2×	76	4.0k
Vincent Camus France	32	231 0.3×	1.0k 2.1×	160 0.4×	843 2.3×	642 1.8×	131	4.4k
Adam Bisaga United States	36	1.1k 1.5×	528 1.1×	1.2k 2.7×	90 0.2×	123 0.3×	114	3.6k
Miriam Adelson Israel	29	1.0k 1.4×	319 0.7×	940 2.2×	74 0.2×	91 0.3×	113	2.9k
Hannu Koponen Finland	39	307 0.4×	2.0k 4.3×	288 0.7×	439 1.2×	217 0.6×	201	4.9k
Maria A. Sullivan United States	38	1.6k 2.2×	527 1.1×	1.2k 2.7×	113 0.3×	90 0.3×	99	3.5k
Marijke A. Bremmer Netherlands	25	236 0.3×	363 0.8×	301 0.7×	311 0.8×	397 1.1×	45	2.6k
Sylvaine Artéro France	30	456 0.6×	2.1k 4.5×	259 0.6×	188 0.5×	141 0.4×	79	4.1k
Margaret Rukstalis United States	29	779 1.1×	278 0.6×	658 1.5×	52 0.1×	76 0.2×	60	2.9k
Michael Soyka Germany	33	393 0.6×	1.0k 2.1×	1.2k 2.8×	149 0.4×	86 0.2×	187	4.1k

Countries citing papers authored by Anna Lembke

Since Specialization

Citations

This map shows the geographic impact of Anna Lembke's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Anna Lembke with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Anna Lembke more than expected).

Fields of papers citing papers by Anna Lembke

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Anna Lembke. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Anna Lembke. The network helps show where Anna Lembke may publish in the future.

Co-authorship network of co-authors of Anna Lembke

This figure shows the co-authorship network connecting the top 25 collaborators of Anna Lembke. A scholar is included among the top collaborators of Anna Lembke based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Anna Lembke. Anna Lembke is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Garel, Nicolas, et al.. (2025). Increased Risks of Major Cardiac Adverse Events in Stimulant Use Disorder as Compared With Other Substance Use Disorders: A Propensity-score Matching Cohort Study. Journal of Addiction Medicine. 19(5). 599–604.

Griffith, Kendall C., Bryan Bunning, Adam S. Miner, et al.. (2025). Predicting treatment retention in medication for opioid use disorder: a machine learning approach using NLP and LLM-derived clinical features. Journal of the American Medical Informatics Association. 32(12). 1865–1876.

Lavertu, Adam, Tymor Hamamsy, Keith Humphreys, et al.. (2025). Monitoring the opioid epidemic via social media discussions. npj Digital Medicine. 8(1). 284–284. 3 indexed citations

Lembke, Anna, David Michaels, Cecília Tomori, et al.. (2024). The opioid industry's use of scientific evidence to advance claims about prescription opioid safety and effectiveness. Health Affairs Scholar. 2(10). qxae119–qxae119. 5 indexed citations

Bertz, Jeremiah W., Adam S. Miner, Tina Hernandez‐Boussard, et al.. (2024). Predictability of buprenorphine‐naloxone treatment retention: A multi‐site analysis combining electronic health records and machine learning. Addiction. 119(10). 1792–1802. 2 indexed citations

Garel, Nicolas, et al.. (2024). Trends in hallucinogen‐associated emergency department visits and hospitalizations in California, USA, from 2016 to 2022. Addiction. 119(5). 960–964. 12 indexed citations

Lembke, Anna, et al.. (2022). Buprenorphine Microdosing Cross Tapers: A Time for Change. International Journal of Environmental Research and Public Health. 19(24). 16436–16436. 2 indexed citations

Lembke, Anna, et al.. (2021). A systematic review of stigma interventions for providers who treat patients with substance use disorders. Journal of Substance Abuse Treatment. 131. 108486–108486. 101 indexed citations

Lembke, Anna, et al.. (2018). Patients Maintained on Buprenorphine for Opioid Use Disorder Should Continue Buprenorphine Through the Perioperative Period. Pain Medicine. 20(3). 425–428. 47 indexed citations

10.

Lembke, Anna, et al.. (2016). Weighing the Risks and Benefits of Chronic Opioid Therapy.. PubMed. 93(12). 982–90. 31 indexed citations

11.

Leyro, Teresa M., Susan W. Bryson, Anna Lembke, et al.. (2016). Retrospective analysis of changing characteristics of treatment-seeking smokers: implications for further reducing smoking prevalence. BMJ Open. 6(6). e010960–e010960. 8 indexed citations

12.

Keller, Jennifer, R Gomez, G Williams, et al.. (2016). HPA axis in major depression: cortisol, clinical symptomatology and genetic variation predict cognition. Molecular Psychiatry. 22(4). 527–536. 606 indexed citations breakdown →

13.

Stein, Michael D., et al.. (2016). Reasons for Benzodiazepine Use Among Persons Seeking Opioid Detoxification. Journal of Substance Abuse Treatment. 68. 57–61. 57 indexed citations

14.

Lembke, Anna & Mark Stanford. (2014). Clinical management of alcohol use disorders in the neurology clinic. Handbook of clinical neurology. 125. 659–670. 2 indexed citations

15.

Schatzberg, Alan F., Jennifer Keller, Lakshika Tennakoon, et al.. (2013). HPA axis genetic variation, cortisol and psychosis in major depression. Molecular Psychiatry. 19(2). 220–227. 100 indexed citations

16.

Re, A. C. Del, Adam J. Gordon, Anna Lembke, & Alex H. S. Harris. (2013). Prescription of topiramate to treat alcohol use disorders in the Veterans Health Administration. Addiction Science & Clinical Practice. 8(1). 12–12. 37 indexed citations

17.

Lembke, Anna. (2012). Why Doctors Prescribe Opioids to Known Opioid Abusers. New England Journal of Medicine. 367(17). 1580–1581. 88 indexed citations

18.

Lembke, Anna, Katharine A. Bradley, Patricia Henderson, Rudolf H. Moos, & Alex H. S. Harris. (2011). Alcohol Screening Scores and the Risk of New-Onset Gastrointestinal Illness or Related Hospitalization. Journal of General Internal Medicine. 26(7). 777–782. 25 indexed citations

19.

DeBattista, Charles & Anna Lembke. (2005). Update on augmentation of antidepressant response in resistant depression. Current Psychiatry Reports. 7(6). 435–440. 9 indexed citations

20.

DeBattista, Charles, et al.. (2004). A Prospective Trial of Modafinil as an Adjunctive Treatment of Major Depression. Journal of Clinical Psychopharmacology. 24(1). 87–90. 105 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact